TCL Archive Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial October 26, 2012
TCL Archive FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion January 3, 1992
TCL Archive Organ Systems Program Success With Concepts Continues as DBD, DCE Boards Okay Five More July 3, 1987
